雅虎香港 搜尋

搜尋結果

1. drugs.olc.tw › licenses › view敏使朗錠6公絲(貝他喜汀) MERISLON TABLETS 6MG (BETAHISTINE ...

   drugs.olc.tw › licenses › view

   • 網頁紀錄

   中文品名. 敏使朗錠6公絲 (貝他喜汀) 英文品名. MERISLON TABLETS 6MG (BETAHISTINE MESILATE) 藥品類別. 須由醫師處方使用. 管制藥品分類級別. 申請商名稱. 衛采製藥股份有限公司.

2. synapse.inc › MerislonMerislon Tablets 12mg(Betahistine Mesilate) by Eisai Co., Lt ...

   synapse.inc › Merislon

   • 網頁紀錄

   Storage Condition. 室温. 1. PRESCRIPTION. “Merislon Tablets 12mg” is a prescription medicine (Rx) in Japan. 2. IMPORT (SUPPORTING) DOCUMENTS. Certificate of Origin (CoO), Patient Information Leaflet (PIL) and Summary of Product Characteristics (SmPC) of “Merislon Tablets 12mg” are available. *PIL and SmPC are written in Japanese.

3. eisaisensei.com › wp-content › uploadsLogin Page - Eisai Sensei

   eisaisensei.com › wp-content › uploads

   Login Page - Eisai Sensei

4. www.drugoffice.gov.hk › eps › drugDrug Office | 藥 物 辦 公 室

   www.drugoffice.gov.hk › eps › drug

   • 網頁紀錄

   2024年5月17日 · MERISLON TAB 6MG Registration No.: HK-48603 Certificate Holder: EISAI (HONG KONG) CO LTD Certificate Holder Address: FLAT/RM D, 18/F, LEE & MAN 169 ELECTRIC ROAD, NORTH POINT, HONG KONG : Part 1 ...

5. pitchbook.com › profiles › companyEisai (Myonal and Merislon Rights in Tokyo, Japan) Company ...

   pitchbook.com › profiles › company

   • 網頁紀錄

   Information on acquisition, funding, investors, and executives for Eisai (Myonal and Merislon Rights in Tokyo, Japan). Use the PitchBook Platform to explore the full profile.

6. www.chemicalregister.com › Eisai_Co_Ltd › SupplierEisai Co Ltd. - Tokyo, Japan @ ChemicalRegister.com

   www.chemicalregister.com › Eisai_Co_Ltd › Supplier

   • 網頁紀錄

   Profile: Eisai Co Ltd. is a manufacturer and exporter of pharmaceutical drugs. We focus on neurology & gastroinstestinal diseases and neurodegenerative diseases. We are accredited with ISO 14001 certification. 13 Products/Chemicals (Click for related suppliers)

7. en.acnnewswire.com › press-release › englishEisai to Divest Rights for Merislon and Myonal in Japan to ...

   en.acnnewswire.com › press-release › english

   • 網頁紀錄

   2024年3月29日 · TOKYO, Mar 29, 2024 - (JCN Newswire) - Eisai Co., Ltd. announced today that it has entered into an agreement to divest its rights for vertigo and equilibrium disturbance treatment Merislon® (generic name: betahistine mesilate) and muscle relaxant Myonal